25
Participants
Start Date
September 5, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2029
endotoxin escherichia coli (E. coli) lipopolysaccharide (LPS)
Intravenous administration of endotoxin (0.8 ng/kg body weight)
Placcebo
Placebo injection of 0.9% NaCl
Department of emergency medicine, Linköping University Hospital, Region Östergötland, Linköping
Karolinska Institutet
OTHER
Stockholm University
OTHER
University Hospital, Linkoeping
OTHER